Stock Price
48.58
Daily Change
0.10 0.21%
Monthly
-0.43%
Yearly
31.37%
Q4 Forecast
47.53

EPS Reference Time Actual Consensus Previous
2026-11-25 54.70 0.36



Peers Price Chg Day Year Date
Ansell 46.41 0.10 0.22% 28.28% Nov/16
A2 Milk 9.00 0.05 0.56% -15.65% Nov/16
Cochlear 150.83 -0.54 -0.36% -44.73% Nov/16
CSL 202.52 -0.40 -0.20% 12.24% Nov/16
EBOS 22.24 0.84 3.93% -24.48% Nov/16
Fisher Paykel Healthcare 48.58 0.10 0.21% 31.37% Nov/16
Healius 0.58 0.01 0.87% -35.91% Nov/16
Nanosonics 2.94 0.11 3.89% -25.38% Nov/16
Ramsay Health Care 54.95 -0.08 -0.15% 74.67% Nov/16
ResMed 35.20 0.24 0.69% -6.26% Nov/16

Indexes Price Day Year Date
NZX 50 14304 130.09 0.92% 5.96% Nov/16

Fisher Paykel Healthcare traded at 48.58 this Monday November 16th, increasing 0.10 or 0.21 percent since the previous trading session. Looking back, over the last four weeks, Fisher Paykel Healthcare gained 0.43 percent. Over the last 12 months, its price rose by 31.37 percent. Looking ahead, we forecast Fisher Paykel Healthcare to be priced at 47.53 by the end of this quarter and at 44.79 in one year, according to Trading Economics global macro models projections and analysts expectations.

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.